A detailed history of Penserra Capital Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Penserra Capital Management LLC holds 1,874 shares of VKTX stock, worth $96,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,874
Previous 1,291 45.16%
Holding current value
$96,567
Previous $68,000 73.53%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$49.84 - $70.47 $29,056 - $41,084
583 Added 45.16%
1,874 $118,000
Q2 2024

Aug 13, 2024

BUY
$47.39 - $80.2 $61,180 - $103,538
1,291 New
1,291 $68,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.95B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.